Recent advancements in cancer treatment involve targeting specific genetic changes. Targeted therapies are designed to specifically target the genetic mutations that drive cancer growth. For instance, HER2 inhibitors are used to treat breast cancers that overexpress the HER2 gene. Similarly, drugs targeting BRAF mutations are used for certain types of melanoma.